[Biological tolerance of the trimethoprim-sulfamethoxazole combination in pediatrics. Its influence on serum folic and folinic acid levels].
D000293:Adolescent; D000367:Age Factors; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D003875:Drug Eruptions / Q000209:etiology; D004361:Drug Tolerance; D005069:Evaluation Studies as Topic; D005260:Female; D005492:Folic Acid / Q000097:blood; D005493:Folic Acid Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D002955:Leucovorin / Q000097:blood; D008297:Male; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use*; D013420:Sulfamethoxazole / Q000009:adverse effects / Q000627:therapeutic use*; D014295:Trimethoprim / Q000009:adverse effects / Q000627:therapeutic use; D014839:Vomiting / Q000139:chemically induced
D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D005492:Folic Acid; D014295:Trimethoprim; D013420:Sulfamethoxazole; D002955:Leucovorin
Etude de la tolérance biologique de l'association triméthoprime-sulfaméthoxazole en pédiatrie. Son influence sur les taux des activités foliques et foliniques sériques.